These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2352806)

  • 1. Periosteal reaction following prostaglandin E1 therapy.
    Pediatr Radiol; 1990; 20(3):212. PubMed ID: 2352806
    [No Abstract]   [Full Text] [Related]  

  • 2. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
    Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
    J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periosteal hyperostosis resulting from prostaglandin therapy.
    Williams JL
    Eur J Radiol; 1986 Aug; 6(3):231-2. PubMed ID: 3769947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plain film and CT observations in prostaglandin-induced bone changes.
    Matzinger MA; Briggs VA; Dunlap HJ; Udjus K; Martin DJ; McDonald P
    Pediatr Radiol; 1992; 22(4):264-6. PubMed ID: 1523047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periosteal reaction induced by prostaglandins.
    Niethammer JG; Rule KA; Lorch V; Anderson ME
    Am J Perinatol; 1992 Jul; 9(4):279-80. PubMed ID: 1627219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical hyperostosis as a side-effect of prolonged use of prostaglandins.
    Rivero Jiménez N; Bret-Zurita M; García-Guereta Silva L
    Cardiol Young; 2016 Jan; 26(1):149-50. PubMed ID: 26423344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical hyperostosis secondary to prolonged use of prostaglandin E1.
    de Almeida JF; Kimura H; Hercowitz LH; Korkes H; Troster EJ
    Clinics (Sao Paulo); 2007 Jun; 62(3):363-6. PubMed ID: 17589681
    [No Abstract]   [Full Text] [Related]  

  • 8. Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review.
    Velaphi S; Cilliers A; Beckh-Arnold E; Mokhachane M; Mphahlele R; Pettifor J
    J Perinatol; 2004 Apr; 24(4):263-5. PubMed ID: 15067299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized periosteal reaction and tissue swelling secondary to prolonged prostaglandin E1 infusion and venous stasis: a case report.
    Alan S; Uçar T; Erdeve O; Atasay B; Arsan S; Atalay S
    Turk J Pediatr; 2013; 55(5):543-5. PubMed ID: 24382539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1-induced hyperostosis: clinicopathologic correlations and possible pathogenetic mechanisms.
    Faye-Petersen OM; Johnson WH; Carlo WA; Hedlund GL; Pacifico AD; Blair HC
    Pediatr Pathol Lab Med; 1996; 16(3):489-507. PubMed ID: 9025848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical Hyperostosis after Long-Lasting Prostaglandin E1 Treatment in a Newborn with Complex Congenital Heart Disease.
    Celona A; Giardina C; Pappalardo S; Secinaro A; Oreto L; Agati S; Romeo P
    J Pediatr; 2020 Nov; 226():302-303. PubMed ID: 32721399
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin induced cortical hyperostosis in neonates with cyanotic heart disease.
    Nadroo AM; Shringari S; Garg M; al-Sowailem AM
    J Perinat Med; 2000; 28(6):447-52. PubMed ID: 11155430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical hyperostosis secondary to prostaglandin E1 therapy.
    Estes K; Nowicki M; Bishop P
    J Pediatr; 2007 Oct; 151(4):441, 441.e1. PubMed ID: 17889087
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone and tissue changes following prostaglandin therapy in neonates.
    Kaufman MB; El-Chaar GM
    Ann Pharmacother; 1996 Mar; 30(3):269-74, 277. PubMed ID: 8833563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary effects of prostaglandin E1 on the management of hypoplastic left heart syndrome while waiting for heart transplantation].
    Caballero S; Torre I; Arias B; Blanco D; Zabala JI; Sánchez Luna M
    An Esp Pediatr; 1998 May; 48(5):505-9. PubMed ID: 9656538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation.
    Daneschvar H; Pacher R; Rödler S; Stanek B; Hülsmann M; Grimm M; Laufer G; Wolner E; Bunzel B
    Wien Klin Wochenschr; 1996; 108(16):510-4. PubMed ID: 8840497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostaglandin E1 on the periosteal regional acceleratory phenomenon in fractured ribs: histomorphometric study in beagles.
    Shih MS; Norrdin RW
    Am J Vet Res; 1987 May; 48(5):828-30. PubMed ID: 3592385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytosis caused by prostaglandin E1 in neonates.
    Arav-Boger R; Baggett HC; Spevak PJ; Willoughby RE
    J Pediatr; 2001 Feb; 138(2):263-5. PubMed ID: 11174627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperostosis: an under-recognized complication of prostaglandin infusion.
    Abdelaziz M; John CM
    Acta Paediatr; 2013 May; 102(5):e192. PubMed ID: 23414095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.